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Objective: To study the effect of hGC-MSCs from human gastric cancer tissue on cell
proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric
cancer tumor-bearing mice.
Methods: BABL/c nude mice were selected as experimental animals and gastric cancer
tumor-bearing mice model were established by subcutaneous injection of gastric cancer
cells, randomly divided into different intervention groups. hGC-MSCs group were given
different amounts of gastric cancer cells for subcutaneous injection, PBS group was given
equal volume of PBS for subcutaneous injection. Then tumor tissue volume were
determined, tumor-bearing mice were killed and tumor tissues were collected, mRNA
expression of proliferation, invasion, EMT-related molecules were determined.
Results: 4, 8, 12, 16, 20 d after intervention, tumor tissue volume of hGC-MSCs group
were signiﬁcantly higher than those of PBS group and the more the number of hGC-
MSCs, the higher the tumor tissue volume; mRNA contents of Ki-67, PCNA, Bcl-2,
MMP-2, MMP-7, MMP-9, MMP-14, N-cadherin, vimentin, Snail and Twist in tumor
tissue of hGC-MSCs group were higher than those of PBS group, and mRNA contents of
Bax, TIMP1, TIMP2 and E-cadherin were lower than those of PBS group.
Conclusion: hGC-MSCs from human gastric cancer tissue can promote the tumor
growth in gastric cancer tumor-bearing mice, and the molecular mechanism includes
promoting cell proliferation, invasion and epithelial-mesenchymal transition.1. Introduction
Mesenchymal stem cells (MSCs) are the stem cells from
mesoderm of early embryo development that have the features
such as highly self-renewal ability, easily transferring into
exogenous genes and oncolytic virus, and weak immunogenicity
[1,2]. Studies in recent years have conﬁrmed that stem cells have
good afﬁnity to solid tumors and participate in the occurrence
and development of a variety of malignant tumors. MSCs
in vitro isolation, culture and ampliﬁcation are relatively easy,
and they are the ideal carrier for the veriﬁcation of malignant
tumor pathogenesis and the targeted treatment of malignanttumors [3–5]. However, the relationship between MSCs and the
occurrence and development of gastric cancer is not yet clear
at present, and in the following study, hGC-MSCs from hu-
man gastric cancer tissue were isolated and cultured, and gastric
cancer tumor-bearing mice model were established, aiming at
verifying the effect of hGC-MSCs from human gastric cancer
tissue on tumor growth of gastric cancer tumor-bearing mice
through animal experiments.
2. Materials and methods
2.1. Materials
Human gastric cancer cell lines SGC-7901 were bought from
the cell bank of Chinese academy of sciences, BABL/c nude
mice were purchased by the university animal center [license:
SCXK (Su) 2011-0003], 1640 culture medium, fetal bovine
serum and trypsin for cell culture were bought from Gibco
Company, and the RNA extraction and PCR detection kits were
bought from Beijing Tiangen Biotech Company.rticle under the CC BY-NC-ND license (http://
Table 2
mRNA contents of proliferation-related molecules in tumor tissue of
every group.
Groups Proliferation-related molecules
Ki-67/b-actin PCNA/b-actin Bcl-2/b-actin Bax/b-actin
2 × 106
hGC-MSCs
2.95 ± 0.32 3.38 ± 0.39 3.14 ± 0.33 0.29 ± 0.28
1 × 106
hGC-MSCs
2.11 ± 0.24 2.28 ± 0.24 2.39 ± 0.25 0.55 ± 0.07
0.5 × 106
hGC-MSCs
1.67 ± 0.18 1.74 ± 0.21 1.49 ± 0.15 0.78 ± 0.09
PBS group 1.00 ± 0.12 1.00 ± 0.11 1.00 ± 0.08 1.00 ± 0.14
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SGC-7901 cell lines were recovered, then cultured with 1640
culturemedium containing 10% fetal bovine serum, ampliﬁed and
then digested with trypsin, cell density was adjusted to 5 × 107/
mL, 200 mL cell suspension was collected and subcutaneously
inoculated in the back of BABL/c nudemice, the volume of tumor
tissue was measured after 8 d, and those with volume more than
0.1 cm3 were collected for subsequent research.
2.3. Separate culture and injection of hGC-MSCs
Fresh gastric carcinoma tissue was collected, saved under
aseptic conditions, sent to the super clean bench, cut up to tissue
fragments of 1 mm3, then inoculated in a Petri dish for 2 h of
adherence, culture medium was added for continuous incubation
for 24 h, half the medium was changed, un-adhered tissue mass
and cells were discarded, medium was changed every 3 d, cells
were digested and sub-cultured after 80%–90% of fusion, and
hGC-MSCs were obtained for treatment. HGC-MSCs group
received injection of 0.5 × 106, 1.0 × 106 and 2.0 × 106 hGC-
MSCs respectively around the transplantation tumor, and PBS
group received injection the same volume of PBS.
2.4. Determination of tumor tissue growth
(1) 0, 4, 8, 12, 16 and 20 d after establishment of tumor-
bearing mice model, the long diameter and short diameter of
tumor were determined, and tumor tissue volume was calculated
according to long diameter × short diameter × short diameter/2;
(2) on the 21 d, tumor-bearing mice were executed and anato-
mized to get tumor tissue, RNA extraction kit was used to
extract RNA and reverse-transcribe it into cDNA, PCR kit was
used for ampliﬁcation and detection, and mRNA contents of Ki-
67, PCNA, Bcl-2, Bax, P53, MMP-2, MMP-7, MMP-9, MMP-
14, TIMP1, TIMP2, E-cadherin, N-cadherin, Vimentin, Snail
and Twist were calculated.
2.5. Statistical methods
SPSS20.0 software was used for analysis, differences among
groups were compared by single factor analysis of variance, the
pair-wise comparison was by LSD method and P < 0.05 indi-
cated statistical signiﬁcance in differences.
3. Results
3.1. hGC-MSCs promoted tumor tissue growth in tumor-
bearing mice
Different doses of hGC-MSCs could all promote the tumor
tissue growth in tumor-bearing mice. At each point in time,Table 1
Tumor tissue volume of all groups (cm3).
Groups
0 d 4 d
2 × 106 hGC-MSCs 0.105 ± 0.012 0.528 ± 0.065 1.229
1 × 106 hGC-MSCs 0.112 ± 0.011 0.394 ± 0.052 0.924
0.5 × 106 hGC-MSCs 0.101 ± 0.010 0.304 ± 0.036 0.683
PBS group 0.108 ± 0.009 0.194 ± 0.020 0.489tumor tissue volume of hGC-MSCs group were signiﬁcantly
higher than those of PBS group, and the larger the dose of hGC-
MSCs, the more signiﬁcant the increase of tumor tissue volume,
and it was signiﬁcantly dose-dependent (see Table 1).
3.2. hGC-MSCs regulated the expression of Ki-67,
PCNA, Bcl-2 and Bax in tumor tissue
Different doses of hGC-MSCs could all increase the
expression of Ki-67, PCNA and Bcl-2, and inhibit the expres-
sion of Bax in tumor tissue. mRNA contents of Ki-67, PCNA
and Bcl-2 in tumor tissue of hGC-MSCs group were higher than
those of PBS group, and mRNA content of Bax was lower than
that of PBS group; the larger the dose of hGC-MSCs, the more
signiﬁcant the change in the mRNA contents of Ki-67, PCNA,
Bcl-2 and Bax, and it was signiﬁcantly dose-dependent (see
Table 2).
3.3. hGC-MSCs regulated the expression of MMPs and
TIMPs in tumor tissue
Different doses of hGC-MSCs could all increase the
expression of MMP-2, MMP-7, MMP-9 and MMP-14, and
inhibit the expression of TIMP1 and TIMP2 in tumor tissue.
mRNA contents of MMP-2, MMP-7, MMP-9 and MMP-14 in
tumor tissue of hGC-MSCs group were higher than those of PBS
group, and mRNA contents of TIMP1 and TIMP2 were lower
than those of PBS group; the larger the dose of hGC-MSCs, the
more signiﬁcant the change in the mRNA contents of MMP-2,
MMP-7, MMP-9, MMP-14, TIMP1 and TIMP2, and it was
signiﬁcantly dose-dependent (see Table 3).
3.4. hGC-MSCs regulated the expression of EMT-
related molecules in tumor tissue
Different doses of hGC-MSCs could all increase the
expression of N-cadherin, Vimentin, Snail and Twist, and inhibit
the expression of E-cadherin in tumor tissue. mRNA contents ofAction time
8 d 12 d 16 d 20 d
± 0.128 1.912 ± 0.228 2.585 ± 0.278 3.255 ± 0.339
± 0.104 1.449 ± 0.179 2.003 ± 0.231 2.783 ± 0.315
± 0.080 1.214 ± 0.097 1.583 ± 0.178 2.218 ± 0.252
± 0.057 0.881 ± 0.094 1.133 ± 0.128 1.331 ± 0.148
Table 3
mRNA contents of MMPs and TIMPs in tumor tissue of every group.
Groups MMPs TIMPs
MMP-2 MMP-7 MMP-9 MMP-14 TIMP1 TIMP2
2 × 106 hGC-MSCs 2.87 ± 0.31 3.22 ± 0.35 2.37 ± 0.28 2.75 ± 0.29 0.33 ± 0.05 0.21 ± 0.03
1 × 106 hGC-MSCs 2.10 ± 0.22 2.29 ± 0.25 1.89 ± 0.22 2.02 ± 0.22 0.57 ± 0.07 0.50 ± 0.06
0.5 × 106 hGC-MSCs 1.67 ± 0.19 1.75 ± 0.14 1.38 ± 0.16 1.69 ± 0.18 0.81 ± 0.09 0.76 ± 0.08
PBS group 1.00 ± 0.14 1.00 ± 0.08 1.00 ± 0.13 1.00 ± 0.12 1.00 ± 0.08 1.00 ± 0.17
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MSCs group were higher than those of PBS group, and mRNA
content of E-cadherin was lower than that of PBS group; the
larger the dose of hGC-MSCs, the more signiﬁcant the change in
the mRNA contents of E-cadherin, N-cadherin, Vimentin, Snail
and Twist, and it was signiﬁcantly dose-dependent (see Table 4).Table 4
mRNA contents of EMT-related molecules in tumor tissue of every group.
Groups EMT marker molecules EMT transcription factors
E-cadherin N-cadherin Vimentin Snail Twist
2 × 106 hGC-MSCs 0.28 ± 0.03 2.38 ± 0.29 2.84 ± 0.33 3.52 ± 0.39 3.24 ± 0.36
1 × 106 hGC-MSCs 0.49 ± 0.06 1.87 ± 0.21 2.04 ± 0.22 2.38 ± 0.25 2.13 ± 0.22
0.5 × 106 hGC-MSCs 0.72 ± 0.09 1.38 ± 0.15 1.54 ± 0.17 1.79 ± 0.22 1.59 ± 0.18
PBS group 1.00 ± 0.12 1.00 ± 0.08 1.00 ± 0.18 1.00 ± 0.14 1.00 ± 0.154. Discussion
Mesenchymal stem cells (MSCs) are a kind of adult stem
cells with features such as highly self-renewal ability, easily
transferring into exogenous genes and oncolytic virus, and weak
immunogenicity, and are associated with the pathogenesis of a
variety of malignant solid tumors. Studies believe that gastric
cancer stem cells are derived from stem cells in the gastroin-
testinal tract, and the above stem cells are in the undifferentiated
state from early embryo development, or dedifferentiated from
mature embryos [6,7]; other studies have conﬁrmed that gastric
cancer stem cells are from bone marrow mesenchymal stem
cell (BMSC), and BMSC can switch phenotype and become
cancer stem cells causing gastric cancer [8,9]. Mesenchymal
stem cells have good afﬁnity to tumors, and can inter-play and
interact with tumor microenvironment after afﬁnity to tumor
tissue, which cannot only adjust the biological characteristics of
tumor cells, but can also change the biological characteristics of
their own [10–13].
The relationship between MSCs and the occurrence and
development of gastric cancer has received more and more
attention and recognition, but most of the studies about MSCs
and gastric cancer use MSCs from normal bone marrow, and
cannot fully simulate the biological characteristics of MSCs in
tumor microenvironment. Study has conﬁrmed that compared
with bone mesenchymal stem cells (BMSCs) from normal bone
marrow, the expression of a variety of genes in mesenchymal
stem cells (hGC-MSCs) from human gastric cancer tissue
changes, and proliferation, invasion and other biological char-
acteristics are also different [14]. In the study, hGC-MSCs were
isolated from fresh human gastric cancer tissue and cultured,
hGC-MSCs were injected around the tumor after establishmentof gastric cancer tumor-bearing mouse model, and measuring the
volume of tumors showed that hGC-MSCs could promote the
growth of gastric cancer tissue in dose-dependent manner.
In the process of gastric cancer tissue growth, tumor cell
proliferation, invasion and other biological behaviors are
signiﬁcantly enhanced, and the expression of a variety of pro-liferation and invasion-related molecules in tumor tissue is
abnormal. HGC-MSCs can regulate the biological behavior of
tumor cells, and in order to determine whether hGC-MSCs
regulated the expression of proliferation and invasion-related
molecules so as to affect the biological behavior of tumor
cells, the contents of biological characteristics-related molecules
in tumor proliferation were determined. PCNA is the accessory
protein for DNA polymerase to be functioning, is the molecule
necessary for intracellular DNA replication and cell prolifera-
tion, Ki-67 is the molecule closely related to the function of
chromatin, and PCNA and Ki-67 are used as cell proliferation
markers [15,16]. Bcl-2 and Bax are the key molecules regulating
mitochondrial apoptosis, Bcl-2 can adjust the opening and
closing of the mitochondrial membrane transition pore, reduce
the release of cytochrome C and restrain the activation of
apoptotic pathways, and Bax can form heterodimer with Bcl-2 to
antagonize the antiapoptotic effect of Bcl-2 and promote cell
apoptosis [17,18]. Analysis in the study showed that different
doses of hGC-MSCs could all increase the expression of Ki-
67, PCNA and Bcl-2, and inhibit the expression of Bax and
P53 in tumor tissue.
Cancer cell invasion is a key link causing tumor tissue
growth and distant metastasis, and can degrade and destruct the
structural barrier formed by extracellular matrix and vascular
wall basement membrane, invade the microcirculation and
migrate to the distant. Matrix metalloproteinases (MMPs) play a
major role in cell degradation of extracellular matrix [19]. MMP-
2, MMP-7, MMP-9 and MMP-14 are the important members of
MMPs family, and can degrade the composition such as
collagen and laminin in the extracellular matrix. In addition,
MMP-14 can also activate MMP-2, MMP-9 and various other
protease molecules [20]. Tissue inhibitor of metalloproteases
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can form covalent bonding with a variety of MMPs molecules
to suppress their proteolysis function. Studies have conﬁrmed
that high expression of MMPs and lower expression of TIMPs
are the important parts causing the occurrence and
development of gastric cancer [21,22]. The analysis in the study
showed that different doses of hGC-MSCs could increase the
expression of MMP-2, MMP-7, MMP-9 and MMP-14, and
inhibit the expression of TIMP1 and TIMP2 in tumor tissue.
Epithelial-mesenchymal transition (EMT) is an important
pathological feature in the occurrence and development of
gastric cancer cells, speciﬁcally refers to the phenomenon of
epithelial cell differentiation to mesenchymal cells under certain
conditions, and is speciﬁcally manifested that the epithelial cells
lose polarity, cells get strong movement ability and intercellular
adhesion ability is decreased [23,24]. E-cadherin is epithelial cell
marker that can maintain cell polarity and adhesion; N-cadherin
and Vimentin are mesenchymal markers that can enhance cell
migration and invasion, and cause invasive cell growth [25]. In
the process of EMT, epithelial cells transit to mesenchymal
cells, the expression of E-cadherin is decreased signiﬁcantly
and the expression of N-cadherin and Vimentin is increased
signiﬁcantly. Snail and Twist are two transcription factors
regulating cell EMT process, and can be combined with the
DNA sequences of epithelial cell and mesenchymal cell
markers to adjust their transcription and thus promote cell
EMT [26,27]. In the study, analysis of EMT in gastric cancer
tissue of tumor-bearing mice showed that different doses of
hGC-MSCs could all promote the process of EMT in gastric
cancer tissue, increase the expression of N-cadherin, Vimentin,
Snail and Twist, and inhibit the expression of E-cadherin.
To sum up, hGC-MSCs from human gastric cancer tissue can
promote the tumor growth in gastric cancer tumor-bearing mice,
and the molecular mechanism includes promoting cell prolifer-
ation, invasion and epithelial-mesenchymal transition.Conﬂict of interest statement
We declare that we have no conﬂict on interest.
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